Cite
HARVARD Citation
Martin, P. et al. (2019). To the Editor, A multicenter, open-label, early access treatment protocol for ibrutinib in patients with relapsed or refractory mantle cell lymphoma. Journal of oncology pharmacy practice. pp. 1027-1030. [Online].